A.D.A.M.

A.D.A.M. (Advanced Development of Additive Manufacturing) is a biotech company that provides 3D-bioprinting services on demand. A.D.A.M. uses its proprietary 3D-printing technology and patented materials to manufacture bioresorbable and biodegradable patient-specific implants (primarily, bone implants). By designing and building an on-demand tissue manufacturing solution, we have been pioneering this technology as a service model to effectively address a complex problem. The business model will... allow patients to have their tissue modelled – using the MRI/CAT scans stored on the digital platform – and, subsequently, 3D-printed and implanted in certified clinics. We reached our main achievement to date in August, as the FDA responded to our Q-Sub (Pre-Submission) confirming our 510(k) regulatory path eligibility. This response means that no human trials and required and a decrease in time to market from 5 years to 1.5-2 years. Additionally, we have been accepted to join Technology Incubation Program at University of Connecticut in Farmington, CT. We have just moved our main office there as TIP offers state of the art research facilities and resources to its member companies. Our intention is to complete the required animal studies there. Finally, we have secured our lead investor for the upcoming Series A round.